SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Current Events and General Interest Bits & Pieces

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Win Smith who wrote (117)12/9/2002 12:24:55 PM
From: Win Smith   of 603
 
Study Suggests Mercury in Vaccine Was Not Harmful nytimes.com

small but groundbreaking study of infants who received vaccines containing a mercury-based preservative has found that the levels of mercury in their blood were well within federal safety limits.

The study, reported on Saturday in the British medical journal The Lancet, also found that infants excrete the mercury much faster than expected, suggesting that it does not build up from one vaccination to the next.

The preservative, thimerosal, is no longer used in American vaccines for infants under 6 months old, but the issue is important to parents of children who did receive thimerosal-containing vaccines as infants and are now autistic. Thousands of those parents have filed damage claims or lawsuits against thimerosal's maker, Eli Lilly & Company, although a clause protecting Lilly from such suits was mysteriously slipped into the domestic security bill signed into law by President Bush on Nov. 25. . . .
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext